Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation

MLA

Segovia, J., et al. Impact of Dose Reductions on Efficacy Outcome in Heart Transplant Patients Receiving Enteric-Coated Mycophenolate Sodium or Mycophenolate Mofetil at 12 Months Post-Transplantation. Jan. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3659..393014a82d6b699fb069c68e0212077b&authtype=sso&custid=ns315887.

APA

Segovia, J., Gerosa, G., Almenar, L., Livi, U., Viganò, M., Arizón, J. M., Yonan, N., Di Salvo, T. G., Renlund, D. G., Kobashigawa, J. A., Aaronson, K., Ahualli, L., Arpesella, G., Crespo, M. G., Davis, S. F., Butler, J., Dengler, T., Egan, J., Eisen, H. J., … Zucker, M. J. (2008). Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation.

Chicago

Segovia, J., G. Gerosa, L. Almenar, U. Livi, M. Viganò, J. M. Arizón, N. Yonan, et al. 2008. “Impact of Dose Reductions on Efficacy Outcome in Heart Transplant Patients Receiving Enteric-Coated Mycophenolate Sodium or Mycophenolate Mofetil at 12 Months Post-Transplantation,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3659..393014a82d6b699fb069c68e0212077b&authtype=sso&custid=ns315887.